http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005057753-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e49b45c89a67990450ac96ea7704686 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca18d04e7d5c6ce2332c02a94891931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_883e9c184d149f5d67efb3f8a84d9c6b |
| publicationDate | 2007-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102005057753-A1 |
| titleOfInvention | Method for the diagnosis of sepsis with IgA |
| abstract | ThenThe present invention relates to a method for in vitro diagnosis,nRisk assessment and / ornFollow-up of sepsis or generalized acute inflammation,nwherein in a sample of a patient the content of immunoglobulinnA and / or further biomarkers and / or derivatives derived therefromndetermines and determines whether the value, relative to a control group,nhigher or highernlower to indicate the presence of sepsis or generalizednacute inflammation, thenCourse and / or the therapeutic success in a sepsis or angeneralized acute inflammationnclose.nThe invention also relates to the use of antibodies againstnIgA and a kit to carry out thenProcess. |
| priorityDate | 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.